Open access
0
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
Jie Shaoa Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, ChinaView further author information
, Kai Xinb Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School,Nanjing University, Nanjing, ChinaView further author information
, Zhaoye Qianc Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, ChinaView further author information
, Fangcen Liud Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School,Nanjing University, Nanjing, ChinaView further author information
, Lin Lia Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, ChinaView further author information
, Junmeng Zhub Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School,Nanjing University, Nanjing, ChinaView further author information
, Qin Liub Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School,Nanjing University, Nanjing, ChinaView further author information
, Manman Tianb Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School,Nanjing University, Nanjing, ChinaView further author information
& Baorui Liua Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China;b Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School,Nanjing University, Nanjing, China;c Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2375825
|
Received 11 Oct 2023, Accepted 01 Jul 2024, Published online: 05 Aug 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.